Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial - Concepedia

Concepedia

Publication | Open Access

Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial

DOI Full Paper Access

105

Citations

28

References

2014

Year

Tim Weaver, Nicola Metrebian, Jennifer Hellier, Stephen Pilling, Vikki Charles, Nicholas Little, Dilkushi Poovendran, Luke Mitcheson, Frank Ryan, Owen Bowden‐Jones,

Abstract

National Institute for Health Research (RP-PG-0707-10149).

References

	Year	Citations
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. John E. Ware, Cathy D. Sherbourne PubMed Quality Of LifeHealth OutcomeItem Response TheoryGeriatric MedicinePrimary Care	1992	34K
The MOS 36-ltem Short-Form Health Survey (SF-36) John E. Ware, Cathy D. Sherbourne Medical Care NursingQuality Of LifePrimary CareHealth PolicyHealthy Aging	1992	29.1K
EuroQol - a new facility for the measurement of health-related quality of life Health Policy Quality Of LifeLife AssessmentHealth PolicyHealth-related QualityNew Facility	1990	15.5K
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II John B. Saunders, Olaf Gjerløw Aasland, Thomas F. Babor, Addiction	1993	13K
Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method Sandra Eldridge, Deborah Ashby, Sally Kerry International Journal of Epidemiology	2006	524
Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index Shane Darke, Wayne Hall, ALEX WODAKI, British Journal of Addiction Opioid EpidemicSubstance UsePharmacotherapyDrug TreatmentMultidimensional Instrument	1992	466
Are booster immunisations needed for lifelong hepatitis B immunity? The Lancet VaccinationVaccine DevelopmentViral HepatitisImmunologyHepatitis B	2000	457
Analysis of cluster randomized trials in primary care: a practical approach Marion Campbell, Jill Mollison, Nick Steen, Family Practice	2000	324
Drug policy and the public good: evidence for effective interventions John Strang, Thomas F. Babor, Jonathan P. Caulkins, The Lancet Public PolicySubstance AbusePreventive MedicineSubstance UseHealth Policy	2012	259
Contingency management in substance abuse treatment. Stephen T. Higgins, Kenneth Silverman, Sarah H. Heil Substance AbuseSubstance UsePsychiatryAddiction TreatmentSubstance Use Treatment	2008	204

Page 1